A systematic review of guidelines for managing rheumatoid arthritis

BMC Rheumatology

Table 4 Drug treatment recommendations

Guideline	DMARDs					Biologics			Symptomatic Treatments
Guideline	MTX	Others	Combinations	JAK Inhibitors	Glucocorticoids (steroids)	First	Subsequent	Tapering	NSAIDs	Pain
1. American [14]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	–	–
2. APLAR [15]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	–
3. Australian [16]	Yes	Yes	Yes	–	Yes	Only for specialists			Yes	Yes
4. Brazilian [17]	Yes	Yes	Yes	–	Yes	Yes	Yes	Yes	Yes	–
5. British Columbia [18]	Yes	Yes	Yes	–	Yes	Only for specialists			Yes	Yes
6. British Society For Rheumatology: Established [19]	Generic DMARDs		–	–	–	Generic biologics			Yes	Yes
7. British Society For Rheumatology: Early [20]	Generic DMARDs		Yes	–	Yes	Generic biologics		Implied	Yes	Yes
8. Canadian [21]	Yes	Yes	Yes	–	Yes	Yes	Yes	Yes	–	–
9. EULAR [22]	Yes	Yes	–	Yes	Yes	Yes	Yes	Yes	–	–
10. French [23]	Yes	Yes	Yes	–	Yes	Yes	Yes	Yes	–	–
11. German [24]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	–	–
12. Hong Kong [25]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	–	–
13. Indian [26]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	Yes	Yes
14. Latin American [27]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	Yes	Yes
15. Mexican [28]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	–	Yes	Yes
16. England [29]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	Yes	Yes
17. Scotland [30]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	Yes	Yes
18. South African [31]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	Yes	Yes
19. Spanish [32]	Yes	Yes	Yes	–	Yes	Yes	Yes	–	Yes	Yes
20. Swedish [33]	Yes	Yes	Yes	–	Yes	Yes	Yes	Yes	–	–
21. Treat to Target [34]	Generic DMARD treatments			–	Yes	Generic biologics		Implied	–	–
22. Turkish [35]	Yes	Yes	Yes	–	Yes	Yes	Yes	Yes	–	–

ISSN: 2520-1026